Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

PURPOSE: Pembrolizumab is active in melanoma, but activity in patients with untreated brain metastasis is less established. We present long-term follow-up of pembrolizumab-treated patients with new or progressing brain metastases treated on a phase II clinical trial (ClinicalTrials.gov identifier: N...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Kluger, Harriet M., Chiang, Veronica, Mahajan, Amit, Zito, Christopher R., Sznol, Mario, Tran, Thuy, Weiss, Sarah A., Cohen, Justine V., Yu, James, Hegde, Upendra, Perrotti, Elizabeth, Anderson, Gail, Ralabate, Amanda, Kluger, Yuval, Wei, Wei, Goldberg, Sarah B., Jilaveanu, Lucia B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2019
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354772/
https://ncbi.nlm.nih.gov/pubmed/30407895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00204
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller